News for ITT Inc. (ITT)

Published at

Apr 24, 2025 9:00 PM

by gurufocus.com

mixed

mixed

Federal Signal Corporation Announces Board Chair Transition

PR NewswireDOWNERS GROVE, Ill., April 24, 2025 DOWNERS GROVE, Ill., April 24, 2025 /PRNewswire/ -- Federal Signal Corporation (NYSE:FSS) (the "Company") to

FSS MOG-B MOG-A ITT 2II.DE

Read more →
Published at

Apr 24, 2025 8:18 PM

by gurufocus.com

positive

positive

ITT Inc (ITT) Shares Up 3.87% on Apr 24

Shares of ITT Inc (ITT) surged 3.87% in mid-day trading on Apr 24. The stock reached an intraday high of $137.49, before settling at $137.39, up from its pr

ITT 2II.DE

Read more →
Published at

Apr 23, 2025 8:16 PM

by gurufocus.com

positive

positive

ITT Inc (ITT) Trading 3.36% Higher on Apr 23

Shares of ITT Inc (ITT) surged 3.36% in mid-day trading on Apr 23. The stock reached an intraday high of $136.48, before settling at $133.97, up from its pr

ITT 2II.DE

Read more →
Published at

Apr 14, 2025 3:50 PM

by gurufocus.com

positive

positive

Stifel Adjusts Price Target for ITT (ITT) Amid Trade Policy Concerns | ITT Stock News

Stifel has revised its price target for ITT Inc. (ITT), reducing it from $179 to $148, while maintaining a Buy rating on the company's shares. This adjustment c

ITT 2II.DE

Read more →
Published at

Apr 14, 2025 2:22 PM

by gurufocus.com

positive

positive

ITT Stock Target Reduced by BofA Amid Tariff Uncertainties | ITT Stock News

BofA Securities analyst Andrew Obin has adjusted his outlook on ITT Inc. (ITT), reducing the price target from $175 to $145 while maintaining a Buy rating on th

ITT 2II.DE

Read more →
Published at

Apr 14, 2025 1:53 PM

by gurufocus.com

positive

positive

Citi Analyst Lowers ITT (ITT) Price Target to $150, Maintains Buy Rating | ITT Stock News

Citi analyst Vladimir Bystricky has adjusted the price target for ITT Inc. (ITT), reducing it from $181 to $150, while maintaining a Buy rating. This update com

ITT 2II.DE

Read more →
Published at

Apr 10, 2025 2:18 PM

by gurufocus.com

positive

positive

ITT (ITT) Announces $500M Share Buyback Plan Under Existing Authorization | ITT Stock News

ITT Inc. (ITT) has announced plans to further engage in its $1 billion share repurchase scheme. With $875 million of the authorization still available as of Mar

ITT 2II.DE

Read more →
Published at

Apr 10, 2025 2:15 PM

by gurufocus.com

positive

positive

ITT Announces Preliminary 2025 First Quarter Results and Intent to Repurchase up to $500 Million of ITT Shares | ITT Stock News

ITT Inc. (ITT) has reported preliminary Q1 2025 results with orders reaching $1.0 billion, marking a 7% growth.The company announced a share repurchase plan of

ITT 2II.DE

Read more →
Published at

Apr 10, 2025 2:01 PM

by gurufocus.com

positive

positive

ITT Inc. Reports Preliminary Q1 2025 Financial Results

On April 10, 2025, ITT Inc (ITT) announced its preliminary unaudited financial results for the first quarter ending March 29, 2025. The company reported a 7% in

ITT 2II.DE

Read more →
Published at

Apr 10, 2025 2:00 PM

by gurufocus.com

positive

positive

ITT Announces Preliminary 2025 First Quarter Results and Intent to Repurchase up to $500 Million of ITT Shares

April 10, 2025-- ITT Inc. (NYSE: [url="]ITT[/url]) today announced its preliminary unaudited financial results for the first quarter ended March 29, 2025. The

ITT 2II.DE

Read more →
Published at

Mar 21, 2025 10:53 PM

by gurufocus.com

positive

positive

ITT Inc Launches VIDAR: A Revolutionary Smart Motor for Industrial Efficiency

Summary On March 18, 2025, ITT Inc (ITT) announced the launch of VIDAR, a groundbreaking compact smart motor with embedded variable speed intelligence designed

ITT 2II.DE

Read more →
Published at

Mar 18, 2025 1:00 PM

by gurufocus.com

positive

positive

ITT Launches VIDAR, A Revolutionary Industrial Smart Motor That Lowers Operating Costs and Drastically Reduces Energy Usage, CO2 Emissions

March 18, 2025-- ITT Inc. (NYSE: [url="]ITT[/url]) today announced the launch of VIDAR, a first of its kind compact smart motor with embedded variable speed in

ITT 2II.DE

Read more →
Published at

Mar 11, 2025 2:45 PM

by zacks.com

positive

positive

Here's Why ITT (ITT) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ITT

Read more →
Published at

Mar 11, 2025 12:02 PM

by manilatimes.net

mixed

mixed

Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial

**media[562978,562979]**

PFE ITT ARVN PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE

Read more →
Published at

Feb 28, 2025 1:02 PM

by gurufocus.com

positive

positive

ITT Inc to Present at Bank of America Global Industrials Conference 2025

Summary ITT Inc (ITT), a leading manufacturer of engineered components and technology solutions, announced its participation in the Bank of America Global Indus

ITT 2II.DE

Read more →
Published at

Feb 28, 2025 1:00 PM

by gurufocus.com

neutral

neutral

ITT Announces Participation at Bank of America Global Industrials Conference 2025 on March 18

February 28, 2025-- ITT Inc. (NYSE: [url="]ITT[/url]) today announced its participation at the Bank of America Global Industrials Conference 2025 in London on

ITT BAC 2II.DE

Read more →
Published at

Feb 22, 2025 10:09 PM

by gurufocus.com

positive

positive

ITT Inc Announces 2025 Capital Markets Day in New York City

Summary ITT Inc (ITT) has announced that it will host its 2025 Capital Markets Day on May 15, starting at 1 p.m. ET in New York City. The event will feature pre

ITT 2II.DE

Read more →
Published at

Feb 20, 2025 3:45 PM

by zacks.com

positive

positive

Why ITT (ITT) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ITT

Read more →
Published at

Feb 7, 2025 8:00 PM

by gurufocus.com

mixed

mixed

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options

PR NewswireNORTH CHICAGO, Ill., Feb. 7, 2025 EMBLAVEOTM is the first and only monobactam/Î²-lactamase inhibitor combination antibiotic therapy approved by

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE ITT ABBV BMY ATCO

Read more →
Published at

Feb 7, 2025 2:25 PM

by zacks.com

neutral

neutral

ITT Beats Q4 Earnings & Revenue Estimates, Issues 2025 EPS View

ITT's Q4 revenues increase 12% year over year, driven by industrial connectors growth in the Connect & Control Technologies segment and short cycle demand in the Industrial Process segment.

ITT

Read more →